Hostname: page-component-7c8c6479df-p566r Total loading time: 0 Render date: 2024-03-29T08:58:12.162Z Has data issue: false hasContentIssue false

Unnecessary shock from an implantable cardioverter-defibrillator following transcutaneous pacing

Published online by Cambridge University Press:  04 March 2015

Riyaz Somani*
Affiliation:
Heart Rhythm Service, Kingston General Hospital, Queen’s University, Kingston, ON
Peggy DeJong
Affiliation:
Heart Rhythm Service, Kingston General Hospital, Queen’s University, Kingston, ON
Kevin Michael
Affiliation:
Heart Rhythm Service, Kingston General Hospital, Queen’s University, Kingston, ON
Adrian Baranchuk
Affiliation:
Heart Rhythm Service, Kingston General Hospital, Queen’s University, Kingston, ON
*
Heart Rhythm Service, Kingston General Hospital, Queen’s University, Kingston, ON K7L 2V7; riyazsomani@hotmail.com

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

As the population ages and cardiovascular disease becomes more prevalent, an increasing number of patients are receiving implantable cardioverter-defibrillators (ICDs). When these patients present to the emergency department, it is imperative that physicians are not only aware of the possible underlying medical issues that may have precipitated their admission but should also have a good understanding of the potential interactions that any medical intervention may have on the patient’s device. We discuss a case in which a patient known to have an ICD in situ was transcutaneously paced for the management of bradycardia, leading to an unnecessary shock.

Type
Case Report • Rapport de cas
Copyright
Copyright © Canadian Association of Emergency Physicians 2014

References

REFERENCES

1. Tokano, T, Bach, D, Chang, J, et al. Effect of ventricular shock strength on cardiac hemodynamics. J Cardiovasc Electrophysiol 1998;9:791–7, doi:10.1111/j.1540-8167.1998.tb00118.x.Google Scholar
2. Yamaguchi, H, Weil, M, Tang, W, et al. Myocardial dysfunction after electrical defibrillation. Resuscitation 2002;54:289–96, doi:10.1016/S0300-9572(02)00149-1.Google Scholar
3. Tung, R, Zimetbaum, P, Josephson, ME. A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death. J Am Coll Cardiol 2008;52:1111–21, doi:10.1016/j.jacc.2008.05.058.Google Scholar
4. Jacob, S, Panaich, SS, Maheshwari, R, et al. Clinical applications of magnets on cardiac rhythm management devices. Europace 2011;13:1222–30, doi:10.1093/europace/eur137.Google Scholar